Matches in SemOpenAlex for { <https://semopenalex.org/work/W2353809675> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W2353809675 endingPage "3" @default.
- W2353809675 startingPage "770" @default.
- W2353809675 abstract "To evaluate the action of Angiotensin II (AngII) on the occurrence and development of diabetic retinopathy and the effect of captopril and valsartan on preventing and treating diabetic retinopathy.Male C57BL/KsJ db/+ mice were obtained at 3 weeks of age and maintained on diets enriched animal fat for 4 weeks. After exposure to high-fat diet for 4 weeks, mice were injected intraperitoneally with streptozotocin (STZ) 100 mg/kg body weight. After 2 weeks, nonfasting plasma glucose concentration was measured by nipping the distal part of the tail. Mice whose plasma glucose concentrations were higher than 11.1 mmol/L were selected for the study as model groups. Starting from day 2, captopril 12.5 mg/kg or valsartan 40 mg/kg was given to treatment group via the oral route After treatment for 4, 8, 12 weeks, respectively, eyeballs of mice from each group were enucleated, embedded in paraffin to make tissue sections for immunohistochemistry analysis. The instrument for computer image-analysis was used to analyze the expression of AngII and VEGF in ganglion cell layer. The analyzed indices were mean gray scale value and area density value.With increased duration of diabetes, the mean gray scale values of AngII and VEGF decreased significantly. At the same time, area density values of AngII and VEGF increased significantly. The area density values of VEGF in captopril treated-group was significantly lower than that in valsartan-treated group for the same duration. Moreover, the area density values of VEGF at 4 weeks was significantly lower than that at 8 weeks or 12 weeks. The area density value in captopril treated-group had a significant negative correlation with diabetes duration. AngII had significant positive correlation with VEGF.AngII possibly participated directly and/or indirectly in the occurrence and development of diabetic retinopathy via the upregulation the expression of VEGF. Early treatment with angiotensin-converting enzyme inhibitors (ACEi) and angiotensin 1 type receptor (AT1R) antagonists could improve diabetic retinopathy to some degree and protect the retinas. The effect of treatment with ACEi was better than that with AT1R antagonists in short term situation." @default.
- W2353809675 created "2016-06-24" @default.
- W2353809675 creator A5043541334 @default.
- W2353809675 creator A5071485774 @default.
- W2353809675 date "2004-11-01" @default.
- W2353809675 modified "2023-09-23" @default.
- W2353809675 title "[The experimental study of captopril and valsartan on the preventing and treatment of diabetic retinopathy in diabetic mice]." @default.
- W2353809675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15634486" @default.
- W2353809675 hasPublicationYear "2004" @default.
- W2353809675 type Work @default.
- W2353809675 sameAs 2353809675 @default.
- W2353809675 citedByCount "0" @default.
- W2353809675 crossrefType "journal-article" @default.
- W2353809675 hasAuthorship W2353809675A5043541334 @default.
- W2353809675 hasAuthorship W2353809675A5071485774 @default.
- W2353809675 hasConcept C126322002 @default.
- W2353809675 hasConcept C134018914 @default.
- W2353809675 hasConcept C2777387769 @default.
- W2353809675 hasConcept C2778313320 @default.
- W2353809675 hasConcept C2779280383 @default.
- W2353809675 hasConcept C2779306644 @default.
- W2353809675 hasConcept C2779479957 @default.
- W2353809675 hasConcept C2779829184 @default.
- W2353809675 hasConcept C555293320 @default.
- W2353809675 hasConcept C71924100 @default.
- W2353809675 hasConcept C84393581 @default.
- W2353809675 hasConceptScore W2353809675C126322002 @default.
- W2353809675 hasConceptScore W2353809675C134018914 @default.
- W2353809675 hasConceptScore W2353809675C2777387769 @default.
- W2353809675 hasConceptScore W2353809675C2778313320 @default.
- W2353809675 hasConceptScore W2353809675C2779280383 @default.
- W2353809675 hasConceptScore W2353809675C2779306644 @default.
- W2353809675 hasConceptScore W2353809675C2779479957 @default.
- W2353809675 hasConceptScore W2353809675C2779829184 @default.
- W2353809675 hasConceptScore W2353809675C555293320 @default.
- W2353809675 hasConceptScore W2353809675C71924100 @default.
- W2353809675 hasConceptScore W2353809675C84393581 @default.
- W2353809675 hasIssue "11" @default.
- W2353809675 hasLocation W23538096751 @default.
- W2353809675 hasOpenAccess W2353809675 @default.
- W2353809675 hasPrimaryLocation W23538096751 @default.
- W2353809675 hasRelatedWork W1963867243 @default.
- W2353809675 hasRelatedWork W1985743555 @default.
- W2353809675 hasRelatedWork W1997756486 @default.
- W2353809675 hasRelatedWork W2009711228 @default.
- W2353809675 hasRelatedWork W2020929702 @default.
- W2353809675 hasRelatedWork W2086894460 @default.
- W2353809675 hasRelatedWork W2140173719 @default.
- W2353809675 hasRelatedWork W2142392245 @default.
- W2353809675 hasRelatedWork W2168119070 @default.
- W2353809675 hasRelatedWork W2353809675 @default.
- W2353809675 hasVolume "40" @default.
- W2353809675 isParatext "false" @default.
- W2353809675 isRetracted "false" @default.
- W2353809675 magId "2353809675" @default.
- W2353809675 workType "article" @default.